EVs surface proteins including CD63, PTK7, EpCAM, LZH8, HER2, PSA and CA25 could be used to distinguish prostate cancer from benign prostatic hyperplasia, as well as recurrence from no recurrence [139]. This evidence concerns the gene PROS1 and prostate carcinoma.